Literature DB >> 25404826

Case report of uterine carcinosarcoma with incisional site recurrence.

Rajshree Katke1, Dilip Sandipan Nikam2, Mehul Bhansali3, B K Smruti4.   

Abstract

Entities:  

Year:  2013        PMID： 25404826      PMCID： PMC4228021          DOI： 10.1007/s13224-012-0345-3

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  6 in total

1.  Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.

Authors:  E Sartori; L Bazzurini; A Gadducci; F Landoni; A Lissoni; T Maggino; P Zola; B La Face
Journal:  Gynecol Oncol       Date:  1997-10       Impact factor: 5.482

2.  Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.

Authors:  Matthew A Powell; Virginia L Filiaci; Peter G Rose; Robert S Mannel; Parviz Hanjani; Koen Degeest; Brigitte E Miller; Nobuyuki Susumu; Frederick R Ueland
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

3.  A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma.

Authors:  Robin A Lacour; Elizabeth Euscher; E Neely Atkinson; Charlotte C Sun; Pedro T Ramirez; Robert L Coleman; Jubilee Brown; Jacalyn B Gano; Thomas W Burke; Lois Michelle Ramondetta
Journal:  Int J Gynecol Cancer       Date:  2011-04       Impact factor: 3.437

4.  Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

Authors:  G P Sutton; J A Blessing; N Rosenshein; G Photopulos; P J DiSaia
Journal:  Am J Obstet Gynecol       Date:  1989-08       Impact factor: 8.661

5.  Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

Authors:  J T Thigpen; J A Blessing; J W Orr; P J DiSaia
Journal:  Cancer Treat Rep       Date:  1986-02

6.  Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.

Authors:  Michael Callister; Lois M Ramondetta; Anuja Jhingran; Thomas W Burke; Patricia J Eifel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.